Equities
Health CarePharmaceuticals & Biotechnology
  • Price (GBX)757.00
  • Today's Change21.00 / 2.85%
  • Shares traded103.50k
  • 1 Year change6.02%
  • Beta0.4272
Data delayed at least 20 minutes, as of Jul 03 2020 16:35 BST.
More ▼

Key statistics

On Friday, Oxford BioMedica PLC (OXB:LSE) closed at 757.00, -11.98% below its 52-week high of 860.00, set on Jun 18, 2020.
52-week range
Today
356.73Mar 18 2020860.00Jun 18 2020
Markit short selling activity
Low
Med
High
Open735.00
High779.00
Low735.00
Bid--
Offer--
Previous close736.00
Average volume260.60k
Shares outstanding82.05m
Free float68.34m
P/E (TTM)--
Market cap621.10m GBP
EPS (TTM)-0.225
GBP
Data delayed at least 20 minutes, as of Jul 03 2020 16:35 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Oxford BioMedica PLC shares was Hold at 672.00 on 06 May 2020Read the full article

Board of Directors

1/8

Dr. Lorenzo Tallarigo, Chairman

2/8

Andrew Heath, Deputy Chairman and Senior Independent Director

3/8

Stuart Henderson, Independent Non-Executive Director

4/8

Martin Diggle, Non-Executive Director

5/8

Heather Preston, Independent Non-Executive Director

6/8

Robert Ghenchev, Non-Executive Director

7/8

John Dawson, Chief Executive Officer

8/8

Stuart Paynter, Chief Financial Officer

Contact

Headquarters and registered address:
Oxford BioMedica plc 
Windrush Court
Transport Way
Oxford
OX4 6LT
United Kingdom

T: +44 (0) 1865 783 000
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.